CLINICAL UNMET NEED: CARDIOLOGY

SOLUTION / CARDIOLOGY



Current diagnostic technologies poorly address early detection of Acute Myocardial Infarction (AMI) and Stroke risk
  • Unlike oncology, physicians lack direct access to diseased arterial tissue or other markers to gauge patient risk levels
  • Several recent studies have validated circulating endothelial cells (CECs) as a biomarker for vascular injury

HaimaChek has developed a biomarker probe (BMProbe) for the in vivo isolation of CECs.

Prototypes are already available for academia use.